ArticleHuman gene therapy2013

Tat-PTD-modified oncolytic adenovirus driven by the SCG3 promoter and ASH1 enhancer for neuroblastoma therapy.

Chuan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.